Recent Updates
Recently added Catalysts
EQ Positive Sentiment

Equillium to Participate in Upcoming Investor Conferences

Thursday, November 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Equillium, Inc. announced its participation in two upcoming investor conferences. The Stifel 2026 Healthcare Conference will feature a fireside chat and 1x1 meetings on November 12. Additionally, the company will attend the Jefferies Global Healthcare Conference in London from November 17 to 19, allowing management to meet with registered investors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Equillium is participating in notable investor conferences.
  • Management will engage directly with investors.
  • The company focuses on innovative therapies for serious conditions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+6%
120-day peak, hindsight
Typical move
9.5%
average across 6 past catalysts
Cash runway
~39 mo
Minimal dilution risk
Lead asset
EQ001
Phase 2 · Acute-graft-versus-host Disease

Full Press Release Details

LA JOLLA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat serious autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:

Stifel 2026 Healthcare Conference Format: Fireside Chat & 1x1 Meetings Date: Thursday, November 12, 2026 Time: 9:20 AM EST

2026 Jefferies Global Healthcare Conference in London Format: 1x1 Meetings Date: Tuesday, November 17 – Thursday, November 19, 2026

Members of the Equillium management team will be available to meet with investors who are registered to attend each conference.
About Equillium Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat serious autoimmune and inflammatory disorders.
For more information, visit www.equilliumbio.com.

Investor Contact PJ Kelleher LifeSci Advisors, LLC +1-617-430-7579 pkelleher@lifesciadvisors.com

Frequently Asked Questions

What conferences will Equillium attend?

Equillium will attend the Stifel and Jefferies conferences.

When is the Stifel Healthcare Conference?

The Stifel Healthcare Conference is on November 12, 2026.

What format will the conferences have?

The conferences will include fireside chats and 1x1 meetings.

Where will the Jefferies Conference take place?

The Jefferies Conference will be held in London.

ShareAdd on Google
Tags: EQ Equillium investor conferences biotechnology autoimmune disorders
Last updated: Nov 5, 2026

Biotech snapshot

Cash runway
$57M liquidity · $1M/mo burn
~39 mo
Minimal dilution risk
Lead asset
EQ001Phase 2
Acute-graft-versus-host Disease →

Catalyst track record

+6%
best trade around EQ's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for EQ.

See every catalyst's timing & PoA →